Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Background Information:
WT161 is a potent,selective,and bioavailable HDAC6 inhibitor. It was created to study the mechanism of action of HDAC6 inhibition in MM (Multiple Myeloma) alone and in combination with Bortezomib (BTZ). WT161 in combination with BTZ triggers significant accumulation of polyubiquitinated proteins and cell stress, followed by caspase activation and apoptosis. More importantly, this combination treatment was effective in BTZ-resistant cells and in the presence of bone marrow stromal cells, which have been shown to mediate MM cell drug resistance. The activity of WT161 was confirmed in our human MM cell xenograft mouse model and established the framework for clinical trials of the combination treatment to improve patient outcomes in MM. (Ref.1)
Reference:
1. Teru Hideshima, et al, Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma, PNAS, 2016, vol. 113, no. 46, p13162–13167.
APIM050346: WT161 (WT-161)
CAS No.: 1206731-57-8.
Molecular Formula: C27H30N4O3.
Molecular Weight: 458.6 (or refer to Certificate of Analysis, batch-specific).
Purity: >98% by HPLC at 254nm.
QC: HPLC-MS, NMR, and quantitative elemental analysis report.
Solubility: Refer to Certificate.
Storage: Refer to Certificate.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.